Emergent BioSolutions to Participate in Investor Conferences
March 01 2021 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that members
of the company’s senior management team will participate in the
following investor conferences:
- Jefferies Inaugural Global Plasma SummitMarch
11, 2021Company fireside chat scheduled at 12:50 pm EST
- KeyBanc Life Sciences & MedTech Investor
ForumMarch 24, 2021Company fireside chat scheduled
at 1:15 pm EST
- Chardan 4th Annual
Manufacturing SummitApril 26-27, 2021Fireside chat date
and time will be updated on the Emergent website as the information
becomes available.
- Truist 7th Annual Life Sciences
SummitMay 4-5, 2021Presentation date and time will be
updated on the Emergent website as the information becomes
available.
For conferences where a presentation is planned, the company’s
webcast presentation may include a discussion of the company's
recent business developments as well as its financial results and
guidance. The webcasts will be available both live, if possible,
and by replay, and will be accessible from the Emergent
website.
About Emergent BioSolutionsEmergent
BioSolutions is a global life sciences company whose mission is to
protect and enhance life. Through our specialty products and
contract development and manufacturing services, we are dedicated
to providing solutions that address public health threats. Through
social responsibility, we aim to build healthier and safer
communities. We aspire to deliver peace of mind to our patients and
customers so they can focus on what’s most important in their
lives. In working together, we envision protecting or enhancing 1
billion lives by 2030. For more information, visit our website and
follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G. BurrowsVice
President, Investor Relations240-631-3280burrowsr@ebsi.com
Media Contact:Nina DeLorenzoSVP, Global
Communications & Public Affairsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024